WELCOME TO LUGANO

It is a pleasure and a honour for us to welcome you in Lugano for the 3rd ATCIP Congress.
The Palazzo dei Congressi, conveniently located at walking distance from the Main Station and downtown, is the ideal venue to host a meeting that we hope will be enjoyable and highly educational. The Meeting’s themes are very exciting and comprehensive, aiming at providing first-hand and up-to-date information on the management of infectious diseases and the most appropriate antimicrobial therapy in critically ill patients.

Immunocompromised and critically ill patients are exposed to viral, bacterial and fungal infections that complicate the already difficult therapy of the underlying diseases. The emergence of resistant viral, bacterial and fungal strains as well as the report of new opportunistic pathogens makes treatment of these patients a daunting task. New antivirals have now expanding the therapeutic options in the treatment of various Hepatitis C conditions and new diagnostic tools as well as antibacterial and antifungal agents are available to support the fight against infectious diseases in rheumatological, ICU and transplant patients, yet viral, bacterial and fungal diseases are still the cause of unacceptably high mortality rates in such patients.

Keynote speakers will highlight the latest progress in research on various aspects of infectious diseases and their therapy in the critically ill. The programme is available here. We hope to see you soon in Lugano for what we are sure will be a very enjoyable and highly educational stay – and of course please take the time to enjoy not only the congress but also the beautiful surroundings. Welcome in Ticino!


OBJECTIVES

Many questions related to the diagnosis and treatment of critically ill and immunocompromised patients are still open: this congress will try and discuss the most common issues and controversies related to infectious diseases in these groups of patients, with the aim of providing not only theoretical but also real-life experience to be then easily translated into daily clinical practice.


WHO SHOULD ATTEND

Infectious disease and intensive care specialists, rheumatologist, oncologists, healthcare professionals, clinical microbiologists, other health professionals involved in the care of critically ill and immunocompromised patients (haemato-oncologists, transplant specialists).

 

CONGRESS PRESIDENT

  • Christian Garzoni, MD, Lugano, Switzerland
 

SCIENTIFIC COMMITTEE

  • Enos Bernasconi, MD, Lugano, Switzerland
  • Luigia Elzi, MD, Locarno, Switzerland
  • Paolo Grossi, MD, Varese, Italy
  • Oscar Marchetti, MD, Nyon, Switzerland
  • Orlando Petrini, PhD, Lugano, Switzerland